Site-Specific Antibody Labeling Service
Controlled. Stable. Reproducible.
PICO BioScience provides a DNA-based, site-specific antibody labeling technology designed for maximum reproducibility, stability, and quantitative control.
Unlike conventional random conjugation methods, our platform ensures a defined number of labels per antibody, enabling consistent performance across batches and applications.
Why Site-Specific Labeling Matters
Traditional antibody labeling methods often introduce variability due to random attachment sites and uncontrolled label density.
This results in batch-to-batch variation, altered binding behavior, and limited assay reproducibility.
PICO BioScience eliminates these limitations by controlling where and how many labels are attached to each antibody molecule.
Defined antibody-to-label ratio
Site-specific conjugation on IgG
Quantitative labeling efficiency calculation
Long-term stability over years
Compatible with stabilizers (e.g., BSA)
How the PICO Labeling Technology Works
Our labeling platform uses a controlled DNA-based conjugation chemistry that attaches oligonucleotide labels at defined positions on the antibody.
Each labeling reaction is optimized and quality-controlled to ensure:
-
Labeling efficiency >95%
-
Structural integrity of the antibody
-
Reproducible performance in downstream assays
The result is a fully characterized, ready-to-use labeled antibody, suitable for quantitative applications.
Ready to Label Your Antibodies with Quantitative Precision?
Discuss your antibody, application, and labeling requirements with our scientific team.
We support you from feasibility assessment to delivery of fully characterized reagents.